 | | IS2 | | 表記: | [(4-ETHYLPHENYL)AMINO]CARBONYLPHOSPHONIC ACID | | 組成式: | C9 H12 N O4 P | | SMILES: | CCc1ccc(NC(=O)[P](O)(O)=O)cc1 | | InChi: | InChI=1S/C9H12NO4P/c1-2-7-3-5-8(6-4-7)10-9(11)15(12,13)14/h3-6H,2H2,1H3,(H,10,11)(H2,12,13,14) | | 別名: | ISO24 | | 定義日: | 2003-06-20 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (4-ethylphenyl)carbamoylphosphonic acid |
|
 | | ISA | | 表記: | 3-(4-IODO-PHENYL)-2-MERCAPTO-PROPIONIC ACID | | 組成式: | C9 H9 I O2 S | | SMILES: | Ic1ccc(cc1)CC(S)C(=O)O | | InChi: | InChI=1S/C9H9IO2S/c10-7-3-1-6(2-4-7)5-8(13)9(11)12/h1-4,8,13H,5H2,(H,11,12)/t8-/m0/s1 | | 別名: | PD150606 | | 定義日: | 1999-07-08 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (2S)-3-(4-iodophenyl)-2-sulfanylpropanoic acid |
|
 | | ISJ | | 表記: | (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid | | 組成式: | C10 H10 O6 | | SMILES: | O=C(O)C1=CC(O/C(C(=O)O)=C)C(O)C=C1 | | InChi: | InChI=1S/C10H10O6/c1-5(9(12)13)16-8-4-6(10(14)15)2-3-7(8)11/h2-4,7-8,11H,1H2,(H,12,13)(H,14,15)/t7-,8-/m1/s1 | | 別名: | Chorismic Acid | | 定義日: | 2011-08-29 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (3R,4R)-3-[(1-carboxyethenyl)oxy]-4-hydroxycyclohexa-1,5-diene-1-carboxylic acid |
|
 | | ISZ | | 表記: | 4-(DIAZENYLCARBONYL)PYRIDINE | | 組成式: | C6 H5 N3 O | | SMILES: | O=C(N=[N@H])c1ccncc1 | | InChi: | InChI=1S/C6H5N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4,7H/b9-7+ | | 別名: | ISONIAZID | | 定義日: | 2004-08-17 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | 4-[(E)-diazenylcarbonyl]pyridine |
|
 | | ITB | | 表記: | 2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE | | 組成式: | C14 H9 N O7 S | | SMILES: | O=C(O)c2cc1ccccc1c3c2S(=O)(=O)N(C3=O)CC(=O)O | | InChi: | InChI=1S/C14H9NO7S/c16-10(17)6-15-13(18)11-8-4-2-1-3-7(8)5-9(14(19)20)12(11)23(15,21)22/h1-5H,6H2,(H,16,17)(H,19,20) | | 別名: | 2-CARBOXYMETHYL-1,3,3-TRIOXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID | | 定義日: | 2006-11-15 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | 2-(carboxymethyl)-1-oxo-1,2-dihydronaphtho[1,2-d]isothiazole-4-carboxylic acid 3,3-dioxide |
|
 | | 8GC | | 表記: | 3-carbamoyl-1-methylpyridin-1-ium | | 組成式: | C7 H9 N2 O | | SMILES: | C(N)(=O)c1ccc[n+](C)c1 | | InChi: | InChI=1S/C7H8N2O/c1-9-4-2-3-6(5-9)7(8)10/h2-5H,1H3,(H-,8,10)/p+1 | | 別名: | 1-methylnicotinamide | | 定義日: | 2017-07-03 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-08-02 | | 識別子(ID): | 3-carbamoyl-1-methylpyridin-1-ium |
|
 | | ITP | | 表記: | PHOSPHORIC ACID MONO-(2,3,4,6-TETRAHYDROXY-5-PHOSPHONOOXY-CYCLOHEXYL) ESTER | | 組成式: | C6 H14 O12 P2 | | SMILES: | O=P(OC1C(O)C(O)C(O)C(OP(=O)(O)O)C1O)(O)O | | InChi: | InChI=1S/C6H14O12P2/c7-1-2(8)5(17-19(11,12)13)4(10)6(3(1)9)18-20(14,15)16/h1-10H,(H2,11,12,13)(H2,14,15,16)/t1-,2-,3+,4+,5+,6- | | 別名: | INOSITOL 1,3-BISPHOSPHATE | | 定義日: | 2001-01-24 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (1R,2s,3S,4R,5s,6S)-2,4,5,6-tetrahydroxycyclohexane-1,3-diyl bis[dihydrogen (phosphate)] |
|
 | | ITT | | 表記: | INOSINE 5'-TRIPHOSPHATE | | 組成式: | C10 H15 N4 O14 P3 | | SMILES: | O=P(O)(O)OP(=O)(O)OP(=O)(O)OCC3OC(n2cnc1c2ncnc1O)C(O)C3O | | InChi: | InChI=1S/C10H15N4O14P3/c15-6-4(1-25-30(21,22)28-31(23,24)27-29(18,19)20)26-10(7(6)16)14-3-13-5-8(14)11-2-12-9(5)17/h2-4,6-7,10,15-16H,1H2,(H,21,22)(H,23,24)(H,11,12,17)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1 | | 別名: | INOSINE TRIPHOSPHATE | | 定義日: | 2004-09-01 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | 9-{5-O-[(S)-hydroxy{[(R)-hydroxy(phosphonooxy)phosphoryl]oxy}phosphoryl]-beta-D-ribofuranosyl}-9H-purin-6-ol |
|
 | | 8HX | | 表記: | 8-hydroxy-3,9-dihydro-1H-purine-2,6-dione | | 組成式: | C5 H4 N4 O3 | | SMILES: | O=C2c1nc(O)nc1NC(=O)N2 | | InChi: | InChI=1S/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12) | | 別名: | 8-hydroxyxanthine | | 定義日: | 2013-10-29 | | 最終更新日: | 2020-06-17 | | 公開日: | 2014-02-05 | | 識別子(ID): | 8-hydroxy-3,9-dihydro-1H-purine-2,6-dione |
|
 | | IVM | | 表記: | (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17
-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacy
clooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside | | 組成式: | C48 H74 O14 | | SMILES: | O=C5OC2CC(OC1(OC(C(C)CC)C(C)CC1)C2)CC=C(C)C(OC4OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C4)C(C=CC=C6COC7C(O)C(=CC5C67O)C)C | | InChi: | InChI=1S/C48H74O14/c1-11-25(2)43-28(5)17-18-47(62-43)23-34-20-33(61-47)16-15-27(4)42(26(3)13-12-14-32-24-55-45-40(49)29(6)19-35(46(51)58-34)48(32,45)52)59-39-22-37(54-10)44(31(8)57-39)60-38-21-36(53-9)41(50)30(7)56-38/h12-15,19,25-26,28,30-31,33-45,49-50,52H,11,16-18,20-24H2,1-10H3/b13-12+,27-15+,32-14+/t25-,26-,28-,30-,31-,33+,34-,35-,36-,37-,38-,39-,40+,41-,42-,43+,44-,45+,47+,48+/m0/s1 | | 別名: | 22,23-DIHYDROAVERMECTIN B1A | | 定義日: | 2011-04-15 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-6'-[(2S)-butan-2-yl]-20,20b-dihydroxy-5',6,8,19-tetramethyl-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside |
|
 | | IY1 | | 表記: | 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile | | 組成式: | C19 H12 N4 O3 | | SMILES: | N#CC=2C(=O)N(c1ccc(cc1)[N+](=O)[O-])c3c(C=2)n(C)c4c3cccc4 | | InChi: | InChI=1S/C19H12N4O3/c1-21-16-5-3-2-4-15(16)18-17(21)10-12(11-20)19(24)22(18)13-6-8-14(9-7-13)23(25)26/h2-10H,1H3 | | 別名: | Indopy-1 | | 定義日: | 2019-03-14 | | 最終更新日: | 2020-06-17 | | 公開日: | 2019-10-23 | | 識別子(ID): | 5-methyl-1-(4-nitrophenyl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile |
|
 | | IYT | | 表記: | N-ALPHA-ACETYL-3,5-DIIODOTYROSYL-D-THREONINE | | 組成式: | C15 H18 I2 N2 O6 | | SMILES: | Ic1cc(cc(I)c1O)CC(C(=O)NC(C(=O)O)C(O)C)NC(=O)C | | InChi: | InChI=1S/C15H18I2N2O6/c1-6(20)12(15(24)25)19-14(23)11(18-7(2)21)5-8-3-9(16)13(22)10(17)4-8/h3-4,6,11-12,20,22H,5H2,1-2H3,(H,18,21)(H,19,23)(H,24,25)/t6-,11+,12-/m1/s1 | | 別名: | THREONINE DERIVATIVE | | 定義日: | 2004-03-03 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | N-acetyl-3,5-diiodo-L-tyrosyl-D-allothreonine |
|
 | | IZN | | 表記: | (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one | | 組成式: | C16 H21 N O3 | | SMILES: | O=C1OCC3=C(C1)C42C(=CCC(OC)C2)CCN4CC3 | | InChi: | InChI=1S/C16H21NO3/c1-19-13-3-2-12-5-7-17-6-4-11-10-20-15(18)8-14(11)16(12,17)9-13/h2,13H,3-10H2,1H3/t13-,16-/m0/s1 | | 別名: | (2S,13bS)-2-Methoxy-2,3,5,6,8,9,10,13-octahydro-1H,12H-benzo[i]pyrano[3,4-g]indolizin-12-one | | 定義日: | 2012-03-06 | | 最終更新日: | 2020-06-17 | | 公開日: | 2012-08-24 | | 識別子(ID): | (4bS,6S)-6-methoxy-1,4,6,7,9,10,12,13-octahydro-3H,5H-pyrano[4',3':3,4]pyrido[2,1-i]indol-3-one |
|
 | | J01 | | 表記: | (2R,3Z,5R)-3-(2-HYDROXYETHYLIDENE)-7-OXO-4-OXA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID | | 組成式: | C8 H9 N O5 | | SMILES: | O=C2N1C(C(/OC1C2)=C/CO)C(=O)O | | InChi: | InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1 | | 別名: | CLAVULANIC ACID | | 定義日: | 2006-11-29 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | (2R,3Z,5R)-3-(2-hydroxyethylidene)-7-oxo-4-oxa-1-azabicyclo[3.2.0]heptane-2-carboxylic acid |
|
 | | 8NA | | 表記: | alpha-Diphosphopyridine nucleotide | | 組成式: | C21 H27 N7 O14 P2 | | SMILES: | NC(=O)c1ccc[n+](c1)[CH]2O[CH](CO[P]([O-])(=O)O[P](O)(=O)OC[CH]3O[CH]([CH](O)[CH]3O)n4cnc5c(N)ncnc45)[CH](O)[CH]2O | | InChi: | InChI=1S/C21H27N7O14P2/c22-17-12-19(25-7-24-17)28(8-26-12)21-16(32)14(30)11(41-21)6-39-44(36,37)42-43(34,35)38-5-10-13(29)15(31)20(40-10)27-3-1-2-9(4-27)18(23)33/h1-4,7-8,10-11,13-16,20-21,29-32H,5-6H2,(H5-,22,23,24,25,33,34,35,36,37)/t10-,11-,13-,14-,15-,16-,20+,21-/m1/s1 | | 別名: | alpha-NAD | | 定義日: | 2013-08-29 | | 最終更新日: | 2020-06-17 | | 公開日: | 2014-08-13 | | 識別子(ID): | [(2R,3S,4R,5S)-5-(3-aminocarbonylpyridin-1-ium-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphate |
|
 | | J0D | | 表記: | 1-methyl-4-[(Z)-(3-methyl-1,3-benzothiazol-2(3H)-ylidene)methyl]quinolin-1-ium | | 組成式: | C19 H17 N2 S | | SMILES: | CN4c1ccccc1SC4=[C@H]c3c2c(cccc2)[n+](cc3)C | | InChi: | InChI=1S/C19H17N2S/c1-20-12-11-14(15-7-3-4-8-16(15)20)13-19-21(2)17-9-5-6-10-18(17)22-19/h3-13H,1-2H3/q+1 | | 別名: | Thiazole orange | | 定義日: | 2018-08-01 | | 最終更新日: | 2020-06-17 | | 公開日: | 2019-07-31 | | 識別子(ID): | 1-methyl-4-[(Z)-(3-methyl-1,3-benzothiazol-2(3H)-ylidene)methyl]quinolin-1-ium |
|
 | | J0M | | 表記: | D-galactonic acid | | 組成式: | C6 H12 O7 | | SMILES: | C(C(C(C(CO)O)O)O)(O)C(O)=O | | InChi: | InChI=1S/C6H12O7/c7-1-2(8)3(9)4(10)5(11)6(12)13/h2-5,7-11H,1H2,(H,12,13)/t2-,3+,4+,5-/m1/s1 | | 別名: | D-galactonate | | 定義日: | 2018-08-02 | | 最終更新日: | 2020-06-17 | | 公開日: | 2019-05-22 | | 識別子(ID): | D-galactonic acid |
|
 | | J11 | | 表記: | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine | | 組成式: | C21 H30 F N5 | | SMILES: | Fc1cccc(c1)CCNCCNC2C(CNC2)Cc3nc(N)cc(c3)C | | InChi: | InChI=1S/C21H30FN5/c1-15-9-19(27-21(23)10-15)12-17-13-25-14-20(17)26-8-7-24-6-5-16-3-2-4-18(22)11-16/h2-4,9-11,17,20,24-26H,5-8,12-14H2,1H3,(H2,23,27)/t17-,20-/m0/s1 | | 別名: | N1-{(3'R,4'S)-4'-[(6"-amino-4"-methylpyridin-2"-yl)methyl]pyrrolidin-3'-yl}-N2-(3'-fluorophenethyl)ethane-1,2-diamine
tetrahydrochloride | | 定義日: | 2009-09-23 | | 最終更新日: | 2020-06-17 | | 識別子(ID): | N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-[2-(3-fluorophenyl)ethyl]ethane-1,2-diamine |
|
 | | 8O7 | | 表記: | N-(2-aminoethyl)-4'-(((4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)thio)methyl)-[1,1'-biphenyl]-4-sulfonami
de | | 組成式: | C22 H24 N4 O3 S2 | | SMILES: | C(N)CNS(=O)(c1ccc(cc1)c2ccc(cc2)CSC4=NC=3CCCC=3C(N4)=O)=O | | InChi: | InChI=1S/C22H24N4O3S2/c23-12-13-24-31(28,29)18-10-8-17(9-11-18)16-6-4-15(5-7-16)14-30-22-25-20-3-1-2-19(20)21(27)26-22/h4-11,24H,1-3,12-14,23H2,(H,25,26,27) | | 別名: | N-(2-aminoethyl)-4'-{[(4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)sulfanyl]methyl}[1,1'-biphenyl]-4-sulfon
amide | | 定義日: | 2017-02-22 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-07-12 | | 識別子(ID): | N-(2-aminoethyl)-4'-{[(4-oxo-4,5,6,7-tetrahydro-3H-cyclopenta[d]pyrimidin-2-yl)sulfanyl]methyl}[1,1'-biphenyl]-4-sulfonamide |
|
 | | 8OR | | 表記: | 2-[[(1S,2S)-2-azanylcyclohexyl]amino]-4-[(4-methylsulfonylphenyl)amino]-6H-pyrido[4,3-d]pyrimidin-5-one | | 組成式: | C20 H24 N6 O3 S | | SMILES: | C[S](=O)(=O)c1ccc(Nc2nc(N[CH]3CCCC[CH]3N)nc4C=CNC(=O)c24)cc1 | | InChi: | InChI=1S/C20H24N6O3S/c1-30(28,29)13-8-6-12(7-9-13)23-18-17-16(10-11-22-19(17)27)25-20(26-18)24-15-5-3-2-4-14(15)21/h6-11,14-15H,2-5,21H2,1H3,(H,22,27)(H2,23,24,25,26)/t14-,15-/m0/s1 | | 別名: | (1S,2S)-2-((4-((4-(methylsulfonyl)phenyl)amino)-5-oxo-5,6-dihydropyrido[4,3-d]pyrimidin-2-yl)amino)cyclohexan-1-aminium | | 定義日: | 2017-08-23 | | 最終更新日: | 2020-06-17 | | 公開日: | 2018-06-27 | | 識別子(ID): | 2-[[(1~{S},2~{S})-2-azanylcyclohexyl]amino]-4-[(4-methylsulfonylphenyl)amino]-6~{H}-pyrido[4,3-d]pyrimidin-5-one |
|
 | | 8OU | | 表記: | 4-[(1-methylindazol-5-yl)amino]-2-(4-oxidanylpiperidin-1-yl)-8H-pyrido[4,3-d]pyrimidin-5-one | | 組成式: | C20 H21 N7 O2 | | SMILES: | Cn1ncc2cc(Nc3nc(nc4CC=NC(=O)c34)N5CCC(O)CC5)ccc12 | | InChi: | InChI=1S/C20H21N7O2/c1-26-16-3-2-13(10-12(16)11-22-26)23-18-17-15(4-7-21-19(17)29)24-20(25-18)27-8-5-14(28)6-9-27/h2-3,7,10-11,14,28H,4-6,8-9H2,1H3,(H,23,24,25) | | 別名: | 2-(4-hydroxypiperidin-1-yl)-4-((1-methyl-1H-indazol-5-yl)amino)pyrido[4,3-d]pyrimidin-5(6H)-one | | 定義日: | 2017-08-23 | | 最終更新日: | 2020-06-17 | | 公開日: | 2018-06-27 | | 識別子(ID): | 4-[(1-methylindazol-5-yl)amino]-2-(4-oxidanylpiperidin-1-yl)-8~{H}-pyrido[4,3-d]pyrimidin-5-one |
|
 | | J2B | | 表記: | O-[(1R,2R,3R)-5-{[(S)-{[(2R,3R,4R,5R)-2-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydro
furan-3-yl]oxy}(sulfanyl)phosphoryl]oxy}-1-(6-amino-9H-purin-9-yl)-1,2-dihydroxypentan-3-yl] dihydrogen (R)-phosphorothioate | | 組成式: | C20 H28 N10 O12 P2 S2 | | SMILES: | C3(C(C(n2c1c(C(N=C(N1)N)=O)nc2)OC3CO)OP(OCCC(C(C(n5c4c(c(ncn4)N)nc5)O)O)OP(=O)(O)S)(=O)S)O | | InChi: | InChI=1S/C20H28N10O12P2S2/c21-14-9-15(24-4-23-14)29(5-25-9)18(35)12(33)7(41-43(36,37)45)1-2-39-44(38,46)42-13-11(32)8(3-31)40-19(13)30-6-26-10-16(30)27-20(22)28-17(10)34/h4-8,11-13,18-19,31-33,35H,1-3H2,(H,38,46)(H2,21,23,24)(H2,36,37,45)(H3,22,27,28,34)/t7-,8-,11-,12-,13-,18-,19-,44+/m1/s1 | | 別名: | cleaved nonhydrolyzable phosphorothioate analog of 2'3' cyclic GMP-AMP | | 定義日: | 2018-08-30 | | 最終更新日: | 2020-06-17 | | 公開日: | 2019-02-06 | | 識別子(ID): | O-[(1R,2R,3R)-5-{[(S)-{[(2R,3R,4R,5R)-2-(2-amino-6-oxo-3,6-dihydro-9H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-3-yl]oxy}(sulfanyl)phosphoryl]oxy}-1-(6-amino-9H-purin-9-yl)-1,2-dihydroxypentan-3-yl] dihydrogen (R)-phosphorothioate (non-preferred name) |
|
 | | 8PR | | 表記: | Paroxetine | | 組成式: | C19 H20 F N O3 | | SMILES: | Fc1ccc(cc1)C2CCNCC2COc3ccc4OCOc4c3 | | InChi: | InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1 | | 別名: | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine | | 定義日: | 2011-07-11 | | 最終更新日: | 2020-06-17 | | 公開日: | 2012-09-21 | | 識別子(ID): | (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine |
|
 | | 8QP | | 表記: | [(1S)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid | | 組成式: | C17 H21 N O3 | | SMILES: | c1(CC)c3c(ccc1)c2CCOC(CC(=O)O)(CC)c2n3 | | InChi: | InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m0/s1 | | 別名: | (S)-Etodolac | | 定義日: | 2017-03-02 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-03-15 | | 識別子(ID): | [(1S)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid |
|
 | | 8QS | | 表記: | [(1R)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid | | 組成式: | C17 H21 N O3 | | SMILES: | C1COC(CC(O)=O)(CC)c2nc3c(c12)cccc3CC | | InChi: | InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)/t17-/m1/s1 | | 別名: | (R)-Etodolac | | 定義日: | 2017-03-02 | | 最終更新日: | 2020-06-17 | | 公開日: | 2017-03-15 | | 識別子(ID): | [(1R)-1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl]acetic acid |
|